Drug profile · INN
eprosartan + hydrochlorothiazide
TEVETEN PLUS 600/12.5
eprosartan + hydrochlorothiazide (TEVETEN PLUS 600/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Viatris Pharmaceuticals Co.,.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — eprosartan + hydrochlorothiazide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
eprosartan + hydrochlorothiazide (TEVETEN PLUS 600/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Viatris Pharmaceuticals Co.,.
Key facts
INN eprosartan + hydrochlorothiazide
Brand TEVETEN PLUS 600/12.5
Originator Viatris Pharmaceuticals Co.,
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is eprosartan + hydrochlorothiazide?
eprosartan + hydrochlorothiazide (TEVETEN PLUS 600/12.5) is an FDA-listed pharmaceutical active ingredient. Associated with Viatris Pharmaceuticals Co.,.
What is the brand name for eprosartan + hydrochlorothiazide?
TEVETEN PLUS 600/12.5 is a marketed brand name for eprosartan + hydrochlorothiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.